6 assets in Ovarian Serous Tumor

Therapeutic assets addressing Ovarian Serous Tumor, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cediranib Ovarian Serous Tumor	National Cancer Institute (NCI)	P3	B (63)
Adriamycin Ovarian Serous Tumor	National Cancer Institute (NCI)	P3	B (60)
Carboplatin Ovarian Serous Tumor	National Cancer Institute (NCI)	P3	B (60)
Olaparib Ovarian Serous Tumor	National Cancer Institute (NCI)	P3	B (60)
Berzosertib Ovarian Serous Tumor	National Cancer Institute (NCI)	P2	CCC (53)
Niraparib Ovarian Serous Tumor	MedSIR	P2	CCC (53)